Zhongyi Mu

Shenyang, 110042, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Hyaluronic acid-based strategies for prostate cancer therapy.

Hyaluronic acid-based strategies for prostate cancer therapy.

Journal: Colloids and surfaces. B, Biointerfaces

Published: November 27, 2025

Cellular crosstalk in doxorubicin-induced cardiotoxicity: underlying mechanisms and therapeutic strategies.

Cellular crosstalk in doxorubicin-induced cardiotoxicity: underlying mechanisms and therapeutic strategies.

Journal: Biochemical pharmacology

Published: October 25, 2025

Signaling pathways and potential therapeutic agents in trastuzumab-induced cardiotoxicity.

Signaling pathways and potential therapeutic agents in trastuzumab-induced cardiotoxicity.

Journal: Apoptosis : an international journal on programmed cell death

Published: July 06, 2025

Ubiquitination: A non-negligible modulator in doxorubicin-induced cardiotoxicity.

Ubiquitination: A non-negligible modulator in doxorubicin-induced cardiotoxicity.

Journal: Chemico-biological interactions

Published: April 01, 2025

Molecular signaling pathways in doxorubicin-induced nephrotoxicity and potential therapeutic agents.

Molecular signaling pathways in doxorubicin-induced nephrotoxicity and potential therapeutic agents.

Journal: International immunopharmacology

Published: August 11, 2024

Knockdown of ADAM8 inhibits the proliferation, migration, invasion, and tumorigenesis of renal clear cell carcinoma cells to enhance the immunotherapy efficacy.

Knockdown of ADAM8 inhibits the proliferation, migration, invasion, and tumorigenesis of renal clear cell carcinoma cells to enhance the immunotherapy efficacy.

Journal: Translational research : the journal of laboratory and clinical medicine

Published: August 04, 2023

A Network Meta-Analysis of the Differences in Effectiveness and Safety between Nivolumab and Targeted Drug Therapy in Metastatic Renal Cell Carcinoma.

A Network Meta-Analysis of the Differences in Effectiveness and Safety between Nivolumab and Targeted Drug Therapy in Metastatic Renal Cell Carcinoma.

Journal: Journal of oncology

Published: January 13, 2022

Germline Mutation Landscape and Associated Clinical Characteristics in Chinese Patients With Renal Cell Carcinoma.

Germline Mutation Landscape and Associated Clinical Characteristics in Chinese Patients With Renal Cell Carcinoma.

Journal: Frontiers in oncology

Published: July 07, 2021

Exosomes-mediated transfer of long noncoding RNA LINC01133 represses bladder cancer progression via regulating the Wnt signaling pathway.

Exosomes-mediated transfer of long noncoding RNA LINC01133 represses bladder cancer progression via regulating the Wnt signaling pathway.

Journal: Cell biology international

Published: August 05, 2020

Prognostic Value of YTHDF2 in Clear Cell Renal Cell Carcinoma.

Prognostic Value of YTHDF2 in Clear Cell Renal Cell Carcinoma.

Journal: Frontiers in oncology

Published: April 01, 2020

MicroRNA-1298-5p inhibits cell proliferation and the invasiveness of bladder cancer cells via down-regulation of connexin 43.

MicroRNA-1298-5p inhibits cell proliferation and the invasiveness of bladder cancer cells via down-regulation of connexin 43.

Journal: Biochemistry and cell biology = Biochimie et biologie cellulaire

Published: October 11, 2019

Silencing of lncRNA AFAP1-AS1 Inhibits Cell Growth and Metastasis in Clear Cell Renal Cell Carcinoma.

Silencing of lncRNA AFAP1-AS1 Inhibits Cell Growth and Metastasis in Clear Cell Renal Cell Carcinoma.

Journal: Oncology research

Published: March 06, 2019

Showing 1-12 of 17

Last Updated: 09/26/2026